VERSANT Zika RNA 1.0 Assay (kPCR)

Qualitative detection for Zika virus

The VERSANT® Zika RNA 1.0 Assay (kPCR)* is a real-time polymerase chain reaction (PCR) assay for the qualitative detection of RNA from the Zika virus in serum, plasma, or urine (collected alongside a patient-matched serum or plasma specimen).

The assay uses a dual-target design and is validated for use on the THERMO FISHER QuantStudio 5, BIO-RAD CFX96, and ABI 7500 Fast Dx thermal cyclers.

Qualitative real-time PCR assay provides:

  • Excellent Assay Performance
  • Sample Handling Simplicity
  • Workflow Efficiency
Neem contact op

Features & Benefits

Excellent Assay Performance

  • High-specificity (no cross-reactivity with other Flaviviruses)
  • Dual-target design improves detection
  • Amplifies and detects all currently identified Zika genotypes: West African (Nigerian cluster), East African (MR766 prototype cluster), and Asian
  • Good specificity when tested against cross-reactive species and high sensitivity with commercially available Zika cultures.

Sample Handling Simplicity

  • Validated for serum, plasma, or urine (collected alongside a patient-matched serum or plasma specimen)
  • 48 tests per kit
  • Internal control (IC) to monitor RNA extraction and PCR efficiency
  • Includes UNG for contamination control

Workflow Efficiency

  • Validated for multiple thermal cyclers (THERMO FISHER QuantStudio 5, BIO-RAD CFX96, and ABI 7500 Fast Dx)
  • Concordant with CDC Zika assay using a variety of patient-matched clinical samples (plasma, serum, and urine)**

**Internal data on file.